| Literature DB >> 29167680 |
Abstract
Advancements in Genome editing technologies have revolutionized the fields of functional genomics and crop improvement. CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat)-Cas9 is a multipurpose technology for genetic engineering that relies on the complementarity of the guideRNA (gRNA) to a specific sequence and the Cas9 endonuclease activity. It has broadened the agricultural research area, bringing in new opportunities to develop novel plant varieties with deletion of detrimental traits or addition of significant characters. This RNA guided genome editing technology is turning out to be a groundbreaking innovation in distinct branches of plant biology. CRISPR technology is constantly advancing including options for various genetic manipulations like generating knockouts; making precise modifications, multiplex genome engineering, and activation and repression of target genes. The review highlights the progression throughout the CRISPR legacy. We have studied the rapid evolution of CRISPR/Cas9 tools with myriad functionalities, capabilities, and specialized applications. Among varied diligences, plant nutritional improvement, enhancement of plant disease resistance and production of drought tolerant plants are reviewed. The review also includes some information on traditional delivery methods of Cas9-gRNA complexes into plant cells and incorporates the advent of CRISPR ribonucleoproteins (RNPs) that came up as a solution to various limitations that prevailed with plasmid-based CRISPR system.Entities:
Keywords: CRISPR ribonucleoproteins; CRISPR/Cas system; disease resistance; gene expression regulation; genome editing; metabolic engineering; nutrition improvement
Year: 2017 PMID: 29167680 PMCID: PMC5682324 DOI: 10.3389/fpls.2017.01932
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
List of targeted genes via CRISPR/Cas9 system in different plant species.
| Plant species | Target gene; gene function | Cas9 promoter; codon optimization of Cas9 | sgRNA promoter | Transformation methods | Multiplex strategy; transformant type | Mutant efficiency; type of mutants | Reference |
|---|---|---|---|---|---|---|---|
| AtPDS3; phytoene desaturase, AtFLS2; flagellin sensitive 2, AtRACK1b, AtRACK1c; receptor for activated C kinase1 | CaMV35SPDK; plant | AtU6 | PEG Protoplast co-transfection and | Transient | 1.1–5.6% | ||
| CHL1, CHL2; magnesium chelatase subunit1 | OsUBQ1; human | OsU3 | Sequential cloning | 81.2%; chimeric | |||
| TRY, CPC, and ETC2; trichome density regulators | P35S; maize | AtU6-26, AtU6-29 | Argo-transformation by floral dip | Golden gate/Gibson assembly | 82.6%; chimeric | ||
| PDS gene; phytoene desaturase | P35S; human | AtU6 | Leaf agroinfiltration | Sequential cloning | 6.7%; chimeric | ||
| PDS, PDR6; phytoene desaturase | 2 × CaMV3; tobacco | AtU6 | PEG protoplast transfection | Transient | 16.27–20.3% | ||
| NtPDR6; ABC transporter | 2 × P35S; tobacco | AtU6-26 | Restriction cloning | 81.8–87.5%; chimeric | |||
| OsSWEET; disease susceptibility gene | OsUbi; rice | OsU6.1, OsU6.2 | Sequential cloning | 12.5% | |||
| OsWaxy; amylose synthase | ZmUbi; rice | OsU3, OsU6a, OsU6b, OsU6c | Golden gate/Gibson assembly | 85.4%; biallelic, homozygous, heterozygous | |||
| Maize ubiquitin promoter | U6a | Agro-transformation in embryogenic calli | – | 42.5% (Gn1a), 67.5% (DEP1), 57.5% (GS3) | |||
| Liguleless1 (LIG1) gene, male fertility genes (Ms26 and Ms45), and acetolactate synthase (ALS) genes (ALS1 and ALS2) | ZmUbi; maize | ZmU6 | Biolistic transformation | Co-delivery | 77–100%; biallelic, heterozygous | ||
| Argonaute 18, dihydroflavonol 4-reductase | PZmUbi | PU6.1, PU6.2 | Protoplast transfection | Sequential cloning | 70% | ||
| TaMLO homologs; repress resistance pathway to powdery mildew | ZmUbi; plant | TaU6 | Particle bombardment of immature embryos | – | 5.6% | ||
| GBSS; starch synthase gene | CaMV 35S | AtU6, StU6 | PEG-mediated protoplast transfection | Restriction cloning | 67% | ||
| ANT1; Anthocyanin biosynthesis | 35S | ANT1; AtU6 | Golden gate | 57.1% heterozygous; 13.1% homozygous | |||
| SIAGO7; biogenesis of trans-acting short interfering RNAs | P35S; human | AtU6 | Agro-transformation of cotyledons | Golden gate | 48%; homozygous, biallelic, chimeric | ||
| 2 × 35S | AtU6-26 | Golden gate | 47.6–81.8% | ||||
| DsRed; red fluorescent protein | CaMV 35S | AtU6 | Agro-transformation of immature embryos | Golden gate | 28% | ||
| PDS; phytoene desaturase | 2 × P35S; plant | AtU3b, AtU3d | Golden gate | 50.9% | |||
| ALS1; encode acetolactate synthase involved in amino acid biosynthesis | EF1A2; soybean | U6-9-1 | Particle bombardment | – | 59–76% | ||
| BolC.GA4; ortholog of Arabidopsis GA4a | CsVMW; humans | At-U6-26 | Agro-transformation of cotyledonary petioles | Golden gate | 10% | ||
| SNF (symbiotic nitrogen fixation) related genes | 2 × 35S | LjU6-1 | – | 35%; biallelic | |||
| FAD2 gene; key enzyme for synthesis of polyunsaturated fatty acids | CaMV35SP | U9P | Golden gate | 60% |
Classification of CRISPR/Cas9 system.
| Class | Type | Subtypes | Organism harboring respective types | Signature Cas proteins | Other core proteins |
|---|---|---|---|---|---|
| Class 1∗ | I | I-A | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas6, Cas7 | |
| I-B | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas6, Cas7 | |||
| I-C | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas7 | |||
| I-D | Cas3, Cas10 | Cas1, Cas2, Cas5, Cas6, Cas7 | |||
| I-E | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas7 | |||
| I-F | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas6, Cas7 | |||
| I-U | Cas3, Cas8 | Cas1, Cas2, Cas5, Cas6, Cas7 | |||
| III | III-A | Cas10 | Cas1, Cas2, Cas5, Cas6, Cas7 | ||
| III-B | Cas10 | Cas1, Cas2, Cas5, Cas6, Cas7 | |||
| III-C | Cas10 | Cas5, Cas7 | |||
| III-D | Cas10 | Cas5, Cas7 | |||
| IV | IV | Csf1 | Cas5, Cas7 | ||
| Class 2∗ | II | II-A | Cas9 | Cas1, Cas2 | |
| II-B | Cas9 | Cas1, Cas2 | |||
| II-C | Cas9 | Cas1, Cas2 | |||
| V | V | Cpf1 | Cas1, Cas2 | ||
| VI | VI | C2c2 | Cas1, Cas2 |
Cas9 variants with their origin and specifications.
| Cas9 nuclease variants | Origin | PAM sites (5′ to 3′) | Specifications | Functions | Reference |
|---|---|---|---|---|---|
| Native Cas9 (SpCas9) | NGG | 100 nt long gRNA | Introduce double stranded breaks; create blunt ends | ||
| Cas9 nickase (Cas9n) | Engineered from | NGG | Mutation in native Cas9 (RuvC or HNH D10, aspartate to alanine substitution) | Generate single stranded break; efficient HDR repair mechanism | |
| dCas9 | Engineered from | NGG | Mutated Cas9 | RNA guided transcription regulation (CRISPRi, CRISPRa); delivers GFP enabling visualization of genetic element dynamics | |
| Dimeric RNA-guided FokI nucleases (RFNs) | Engineered from | NGG | Fusion of dCas9 protein and FokI nuclease domain | High genome editing frequency and reduced off-target mutations | |
| NmCas9 | NNNNGATT | Longer crRNA component (24 nt) | Reduced off-target effects | ||
| StCas9 | NNAGAAW | On target cleavage activities | Reduced off-target effects | ||
| SaCas9 | NNGRRT or NNGRR(N) | On target cleavage activities | Reduced off-target effects | ||
| Cas9-DD (Destabilized Cas9) | NGG | Conjugation of destabilized domain to Cas9 | Temporal, spatial and locus-specific control of gene expression; Increased NHEJ- mediated gene insertion efficiency | ||
| Cpf1 | NTT | Contain a RuvC-like endonuclease domain, lack HNH endonuclease domain; 42 nt long gRNA | Require one RNA (crRNA); Produce staggered cut ends; easier to deliver in low capacity vectors ex. AAV |
Different plasmids with specific Cas9 activity.
| Crop | Plasmid | Gene/insert name | Promoter | Selectable Marker | Cas9 type | Significance | Reference | |
|---|---|---|---|---|---|---|---|---|
| sgRNA expression | Cas9 expression | |||||||
| pRGEB32 | PTG1/Cas9 | U3 snoRNA | Rice ubiquitin | Hygromycin | Cut | Enhanced multiplex editing capability via endogenous tRNA processing system | ||
| pHSE401 | gRNA scaffold | AtU6-26 | 35S | Hygromycin | Cut | Improved designing of CRISPR/Cas9 binary vector. Easy method for one or more gRNA assembly in expression cassette, high efficiency mutant generation | ||
| pKI 1.1R | Human codon optimized spCas9 | U6-26p | CaMV35S, WOX2, RPS5A | Hygromycin | Cut | pKIR vector harboring | ||
| pYPQ159 | hSpCas9D10A (human codon optimized) | AtU6-26 | 2× 35S | Spectinomycin | Nick | This toolbox provides reagents to efficiently assemble DNA constructs for monocots and dicots using Golden Gate cloning | ||
| pBUN501 | zCas9D10A | AtU6-26 | Ubi1 | Bar | Nick | Multiplex genome editing | ||
| pHSN6A01 | dCas9-VP64, gRNA scaffold | AtU6-26p | 2× 35Sp | Hygromycin | Activate | Multiplex genome editing | ||
| pBUN6A11 | dCas9-VP64, gRNA scaffold | OsU3p | Ubi1p | Bar | Activate | Multiplex genome editing | ||
| pEGB 35S:dCas9:Tnos (GB1191) | dCas9 | AtU6-26 | 35S, Tnos | Kanamycin | Interfere | GoldenBraid 2.0 validation- foster DNA exchange for synthetic biology; protein-protein interaction tool, gene silencing tool | ||
| pdCas9 (GB1079) | Mutated Cas9 (D10A, H840A) and inactivated catalytic domains (human codon optimized) | U6-26 | pNOS | Ampicillin | Interfere | GoldenBraid gRNA-Cas9 toolbox validated; multiple TDNA cloning, gRNA multiplexing; effective transcriptional activation and repression | ||
List of some crops that are made resistant to diseases via CRISPR/Cas9 system.
| Crop | Disease/symptoms | Causal/target organism | Targeted gene | Significance | Reference |
|---|---|---|---|---|---|
| Powdery mildew disease | Simultaneous modification in three homoeoalleles, heritable broad spectrum resistance to powdery mildew | ||||
| Bacterial blight of rice | PEG stimulated Cas9/sgRNA gene uptake in rice protoplast ( | ||||
| Rice blast disease | 42% T0 mutant lines; 6 T2 homozygous mutants showed high blast resistance and have same agronomic traits | ||||
| Turnip mosaic virus disease | Mutants show no growth defects, morphologically similar to wild type | ||||
| Cotton leaf curl disease | Targeted cleavage of mixed infections by multiple viruses and associated DNA satellites, such as CLCuD-complex | ||||
| Ring spot disease, vein yellowing disease | eLF4E disruption generated virus resistant heterozygous non-transgenic mutants | ||||
| Leaf thickening, chlorosis, curling | 87% reduction in targeted viral load. Study proved that IR targeting via sgRNA confer better resistance | ||||
| Leaf curl disease | Mutants showed delayed and reduced viral DNA accumulation |